📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: iGenomX

1.1 - Company Overview

iGenomX Logo

iGenomX

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of DNA sequencing technology advancing NGS library preparation to enable clinical sequencing for recessive genetic disorders and detect all genetic variation, addressing limitations of commercial tests that miss nearly 30 percent of known causal mutations.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to iGenomX

Seven Bridges Logo

Seven Bridges

HQ: United States Website
  • Description: Provider of cloud-based infrastructure and data analytics for biomedical research, delivering the Seven Bridges Platform for storing, analyzing and interpreting bioinformatic data; BioInfoMiner for unsupervised genomic interpretation; RHEO for custom automation; GRAF for graph-based NGS variant calling; and ARIA for high-throughput molecular and health data cohort analysis at million-participant scale, with services and support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seven Bridges company profile →
Biotheranostics Logo

Biotheranostics

HQ: United States Website
  • Description: Provider of commercial-stage molecular diagnostics, delivering diagnostic, prognostic, and predictive tests that support physicians in treating cancer, including Breast Cancer Index, a genomic test predicting benefit of extended endocrine therapy in HR+, early-stage breast cancer, and CancerTYPE ID, a gene expression assay identifying tumor type/subtype in metastatic cancer with unknown or unclear diagnoses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biotheranostics company profile →
Syros Logo

Syros

HQ: United States Website
  • Description: Provider of a gene control platform that systematically analyzes regulatory regions of the genome to develop small-molecule medicines that control gene expression, and developer of oral therapeutics including tamibarotene (selective RARα agonist) in clinical development for genomically defined HR-MDS and AML, and previously clinical assets SY-2101 (oral arsenic trioxide for APL) and SY-5609 (CDK7 inhibitor for pancreatic cancer).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Syros company profile →
Denovo Biopharma Logo

Denovo Biopharma

HQ: United States Website
  • Description: Provider of biomarker-driven personalized drug development, advancing a pipeline of therapeutics: DB107, a cancer-selective immunotherapy combining gene therapy with a prodrug conversion strategy; DB102 (enzastaurin) guided by DGM1 for DLBCL/GBM; psychiatric candidates DB104 (TRD), DB103 (mGlu2/3), DB105 for Alzheimer’s; and oncology agent DB106 (vosaroxin) for AML and solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Denovo Biopharma company profile →
Lysogene Logo

Lysogene

HQ: France Website
  • Description: Provider of basic research and clinical development of gene therapy for neurodegenerative disorders, developing AAV vectors, with a mission to improve the health of patients with incurable, life-threatening conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lysogene company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for iGenomX

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to iGenomX

2.2 - Growth funds investing in similar companies to iGenomX

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for iGenomX

4.2 - Public trading comparable groups for iGenomX

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to iGenomX

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About iGenomX

What does iGenomX do?

iGenomX is a provider of DNA sequencing technology advancing NGS library preparation to enable clinical sequencing for recessive genetic disorders and detect all genetic variation, addressing limitations of commercial tests that miss nearly 30 percent of known causal mutations.

Who are iGenomX's competitors?

iGenomX's competitors and similar companies include Seven Bridges, Biotheranostics, Syros, Denovo Biopharma, and Lysogene.

Where is iGenomX headquartered?

iGenomX is headquartered in United States.

How many employees does iGenomX have?

iGenomX has 1,000 employees 🔒.

When was iGenomX founded?

iGenomX was founded in 2010 🔒.

What sector and industry vertical is iGenomX in?

iGenomX is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for iGenomX

Who are the top strategic acquirers in iGenomX's sector and industry

Top strategic M&A buyers and acquirers in iGenomX's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for iGenomX?

Top strategic M&A buyers groups and sectors for iGenomX include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in iGenomX's sector and industry vertical

Which are the top PE firms investing in iGenomX's sector and industry vertical?

Top PE firms investing in iGenomX's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in iGenomX's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in iGenomX's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in iGenomX's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to iGenomX include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in iGenomX's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for iGenomX?

The key public trading comparables and valuation benchmarks for iGenomX include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for iGenomX for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for iGenomX with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in iGenomX's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for iGenomX with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in iGenomX's' sector and industry vertical?

Access recent funding rounds and capital raises in iGenomX's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for iGenomX